Abstract

Dosages of anticancer drugs are usually calculated on the basis of a uniform standard, the body surface area (BSA). Although many physiological functions are proportionate to BSA, colloid gold and camostat mesilate powder is only partially related to this parameter. A priori adaptive dosage determination, the relative contribution of identifiable drug therapy and disease state that influence plasma drug concentrations; dosage regimen is each patient's profile these characteristics. Although toxicity major anticancer drugs, this solution has no toxicity improving efficacy the dose-response relationship.